Oya K - Search Results

1

Oya K, Saito A. Oya K, et al. Skin Health Dis. 2023 Dec 6;4(2):e319. doi: 10.1002/ski2.319. eCollection 2024 Apr. Skin Health Dis. 2023. PMID: 38577054 Free PMC article.

2

Pemphigoid without mucous involvement showing IgG antibodies to the β3 subunit of laminin-332.

Miyahara H, Oya K, Kubota N, Ishii N, Nomura T. Miyahara H, et al. Among authors: oya k. J Dtsch Dermatol Ges. 2024 Apr;22(4):570-573. doi: 10.1111/ddg.15318. Epub 2024 Feb 7. J Dtsch Dermatol Ges. 2024. PMID: 38326082 No abstract available.

3

Pemphigoid ohne Schleimhautbeteiligung, mit IgG‐Antikörpern gegen die β3‐Untereinheit von Laminin‐332: Pemphigoid without mucous involvement showing IgG antibodies to the β3 subunit of laminin‐332.

Miyahara H, Oya K, Kubota N, Ishii N, Nomura T. Miyahara H, et al. Among authors: oya k. J Dtsch Dermatol Ges. 2024 Apr;22(4):570-573. doi: 10.1111/ddg.15318_g. J Dtsch Dermatol Ges. 2024. PMID: 38574035 German. No abstract available.

4

COVID-19-associated pemphigus foliaceus exacerbated by toll-like receptor 7 agonist.

Oya K, Ishii Y, Takeyama S, Homma Y, Nomura T. Oya K, et al. J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17215. Online ahead of print. J Dermatol. 2024. PMID: 38629722 No abstract available.

5

Milia-like appearance of vulvar syringoma.

Yasunaga S, Oya K, Ishii Y, Anju K, Takano A, Nomura T. Yasunaga S, et al. Among authors: oya k. J Dermatol. 2024 Apr 20. doi: 10.1111/1346-8138.17219. Online ahead of print. J Dermatol. 2024. PMID: 38641911 No abstract available.

6

Skin fragility: Caution is required with the use of pain relief patches during enfortumab vedotin treatment.

Matsuyoshi N, Oya K, Nomura T. Matsuyoshi N, et al. Among authors: oya k. J Dermatol. 2023 Sep;50(9):e303-e304. doi: 10.1111/1346-8138.16809. Epub 2023 Apr 18. J Dermatol. 2023. PMID: 37073099 No abstract available.

7

Response to 'Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin'.

Oya K, Nakamura Y, Fujisawa Y, Nomura T. Oya K, et al. Br J Dermatol. 2022 Aug;187(2):275. doi: 10.1111/bjd.21230. Epub 2022 May 3. Br J Dermatol. 2022. PMID: 35261023 No abstract available.

8

Enfortumab vedotin-induced cutaneous adverse events manifesting as miliaria-like eruptions with the presence of keratinocyte apoptosis in clinically intact skin.

Oya K, Nakamura Y, Iwamoto K, Kimura T, Negoro H, Nishiyama H, Fujisawa Y. Oya K, et al. J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e1009-e1011. doi: 10.1111/jdv.18406. Epub 2022 Jul 13. J Eur Acad Dermatol Venereol. 2022. PMID: 35789043 No abstract available.

9

Multiple subepidermal calcified nodule confined to café-au-lait spots.

Kakurai M, Oya K, Ishii Y, Nomura T. Kakurai M, et al. Among authors: oya k. J Dermatol. 2023 Aug;50(8):e232-e233. doi: 10.1111/1346-8138.16755. Epub 2023 Feb 23. J Dermatol. 2023. PMID: 36815390 No abstract available.

10

Radiation recall dermatitis induced by eribulin mesylate.

Kiyohara S, Oya K, Nomura T. Kiyohara S, et al. Among authors: oya k. J Dtsch Dermatol Ges. 2023 Nov;21(11):1405-1406. doi: 10.1111/ddg.15200. Epub 2023 Aug 7. J Dtsch Dermatol Ges. 2023. PMID: 37548287 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

178 results

Search Page